• Tirzepatide in Focus: A New Hope for Heart Failure and Obesity - Insights from the SUMMIT Trial

  • Nov 20 2024
  • Length: 14 mins
  • Podcast

Tirzepatide in Focus: A New Hope for Heart Failure and Obesity - Insights from the SUMMIT Trial

Listen for free

View show details

  • Summary

  • In this episode of the HeartBeat Podcast, we explore the groundbreaking findings of the SUMMIT Trial, which evaluated the effects of tirzepatide in patients with heart failure with preserved ejection fraction (HFpEF) and obesity. The study revealed a remarkable 38% reduction in the combined risk of cardiovascular death and worsening heart failure events in patients treated with tirzepatide compared to placebo.

    Join us as we delve into the details of this international, randomized, placebo-controlled trial, including its impact on clinical outcomes, quality of life improvements, and the implications for managing HFpEF patients with obesity. Could tirzepatide be a game-changer for heart failure treatment? Tune in to find out.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Tirzepatide in Focus: A New Hope for Heart Failure and Obesity - Insights from the SUMMIT Trial

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available